Issue Navigation
-
Policy Forum
-
261-265
Song PP, Gao JJ, Kokudo N, Tang W
Drug Discov Ther. 2011; 5(6):261-265.
DOI: 10.5582/ddt.2011.v5.6.261
-
266-278
Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1.
Maruta H
Drug Discov Ther. 2011; 5(6):266-278.
DOI: 10.5582/ddt.2011.v5.6.266
-
279-285
Zhan P, Yan RZ, Liu XY, Pannecouque C, Witvrouw M, De Clercq E, Molina MT, Vega S
Drug Discov Ther. 2011; 5(6):279-285.
DOI: 10.5582/ddt.2011.v5.6.279
-
286-292
A new cell-based reporter system for sensitive screening of nuclear export inhibitors.
Abkallo HM, Kawano H, Watanabe K, Kobayashi N
Drug Discov Ther. 2011; 5(6):286-292.
DOI: 10.5582/ddt.2011.v5.6.286
-
293-298
Zheng WY, Kang YY, Li LF, Xu YX, Ma XY
Drug Discov Ther. 2011; 5(6):293-298.
DOI: 10.5582/ddt.2011.v5.6.293
-
299-305
Ferulic acid induces heme oxygenase-1 via activation of ERK and Nrf2.
Ma ZC, Hong Q, Wang YG, Liang QD, Tan HL, Xiao CR, Tang XL, Shao S, Zhou SS, Gao Y
Drug Discov Ther. 2011; 5(6):299-305.
DOI: 10.5582/ddt.2011.v5.6.299
-
306-310
In vitro bactericidal activity against periodontopathic bacteria by electrolyzed ion-reduced water.
Okajima M, Kanzaki M, Ishibashi Y, Wada Y, Hino F, Kitahara Y, Shimokawa K, Ishii F
Drug Discov Ther. 2011; 5(6):306-310.
DOI: 10.5582/ddt.2011.v5.6.306
-
311-318
Preparation and evaluation of fenoterol hydrobromide suppositories.
Ghorab D, Refai H, Tag R
Drug Discov Ther. 2011; 5(6):311-318.
DOI: 10.5582/ddt.2011.v5.6.311
-
319-321
-
322-326